Linalool and Geraniol Defend Neurons from Oxidative Stress, Inflammation, and Iron Accumulation in In Vitro...

Area of Science:

• Neuroscience
• Pharmacology
• Natural Product Chemistry

Background:

• Parkinson's disease (PD) is a prevalent neurodegenerative disorder with a growing need for complementary therapies.
• Essential oils and their compounds are explored for treating various diseases, including neurodegenerative disorders.
• Linalool and geraniol are key compounds in lavender and geranium essential oils, respectively.

Purpose of the Study:

• To investigate the neuroprotective effects of linalool and geraniol on in vitro Parkinson's disease models.
• To evaluate their impact on oxidative stress, inflammation, and iron metabolism.
• To compare their efficacy with rasagiline, a standard PD treatment.

Main Methods:

• Utilized rotenone and 6-hydroxydopamine-induced in vitro models using differentiated SH-SY5Y cells.
• Assessed reactive oxygen species levels and antioxidant capacity.
• Measured pro-inflammatory cytokine secretion (IL-6, IL-8, IL-1β).
• Analyzed iron-related gene expression and intracellular iron content.

Main Results:

• Linalool and geraniol significantly reduced reactive oxygen species and modulated antioxidant capacity.
• Both compounds decreased the secretion of key pro-inflammatory cytokines.
• They altered the expression of iron metabolism genes (transferrin receptor 1, heme-oxygenase-1, ferroportin) and intracellular iron levels.
• The effects were linked to iron availability.

Conclusions:

• Linalool and geraniol demonstrate significant neuroprotective effects in cellular models of Parkinson's disease.
• These essential oil compounds offer potential as alternative therapies by targeting oxidative stress, inflammation, and iron dysregulation.
• Further research into their therapeutic potential for Parkinson's disease is warranted.